Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,656 | 344 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $827.81 | 52 | $0 (2024) |
| Lilly USA, LLC | $809.09 | 49 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $699.31 | 36 | $0 (2024) |
| Novo Nordisk Inc | $380.29 | 25 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $336.27 | 21 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $293.48 | 18 | $0 (2024) |
| Merck Sharp & Dohme LLC | $246.38 | 16 | $0 (2023) |
| Amgen Inc. | $227.74 | 15 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $164.64 | 11 | $0 (2022) |
| GlaxoSmithKline, LLC. | $160.70 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,227 | 60 | ABBVIE INC. ($314.67) |
| 2023 | $973.76 | 53 | Lilly USA, LLC ($163.37) |
| 2022 | $1,227 | 87 | ABBVIE INC. ($208.25) |
| 2021 | $1,304 | 83 | Lilly USA, LLC ($294.35) |
| 2020 | $589.46 | 39 | Lilly USA, LLC ($102.33) |
| 2019 | $103.98 | 8 | Allergan Inc. ($17.55) |
| 2018 | $92.83 | 7 | SANOFI-AVENTIS U.S. LLC ($30.86) |
| 2017 | $137.71 | 7 | Allergan Inc. ($79.96) |
All Payment Transactions
344 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Respiratory | ||||||
| 12/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Gastroenterology | ||||||
| 10/30/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: DIABETES | ||||||
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: DIABETES | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Respiratory | ||||||
| 10/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: PAIN | ||||||
| 10/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $30.72 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Respiratory | ||||||
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Respiratory | ||||||
| 09/17/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Oncology | ||||||
| 09/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Respiratory | ||||||
| 08/21/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Respiratory | ||||||
| 08/20/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $27.76 | General |
| Category: NEUROSCIENCE | ||||||
| 08/19/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Gastroenterology | ||||||
| 08/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: DIABETES | ||||||
| 07/31/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/30/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.07 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/23/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 457 | 659 | $81,295 | $38,053 |
| 2022 | 8 | 399 | 572 | $60,831 | $27,003 |
| 2021 | 8 | 590 | 769 | $75,922 | $35,587 |
| 2020 | 8 | 598 | 757 | $73,406 | $30,516 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 152 | 275 | $47,986 | $20,482 | 42.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 41 | 41 | $8,815 | $5,025 | 57.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 15 | 15 | $7,935 | $4,224 | 53.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 33 | 33 | $4,508 | $2,367 | 52.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 34 | 38 | $4,675 | $2,034 | 43.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 119 | 194 | $2,510 | $1,630 | 64.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 37 | 37 | $1,443 | $1,075 | 74.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $2,838 | $779.21 | 27.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 15 | 15 | $585.00 | $436.62 | 74.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 133 | 226 | $39,098 | $17,403 | 44.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 55 | 63 | $7,686 | $2,727 | 35.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 21 | 21 | $4,515 | $2,636 | 58.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 22 | 22 | $2,530 | $1,508 | 59.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $3,354 | $1,294 | 38.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 24 | 24 | $936.00 | $655.57 | 70.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 119 | 191 | $2,292 | $561.17 | 24.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 12 | 12 | $420.00 | $217.75 | 51.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 185 | 271 | $46,049 | $21,234 | 46.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 90 | 108 | $12,496 | $5,874 | 47.0% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 54 | 54 | $4,752 | $3,524 | 74.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 18 | 18 | $3,855 | $2,277 | 59.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 14 | 14 | $3,612 | $1,080 | 29.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 54 | 54 | $2,106 | $848.72 | 40.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 162 | 237 | $2,844 | $703.76 | 24.7% |
| 81002 | Urinalysis, manual test | Office | 2021 | 13 | 13 | $208.00 | $45.24 | 21.8% |
About Dr. Charles Coyne, M.D
Dr. Charles Coyne, M.D is a Family Medicine healthcare provider based in Warrenton, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/22/2010. The National Provider Identifier (NPI) number assigned to this provider is 1295048031.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Coyne, M.D has received a total of $5,656 in payments from pharmaceutical and medical device companies, with $1,227 received in 2024. These payments were reported across 344 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($5,656).
As a Medicare-enrolled provider, Coyne has provided services to 2,044 Medicare beneficiaries, totaling 2,757 services with total Medicare billing of $131,159. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Warrenton, MO
- Active Since 07/22/2010
- Last Updated 12/15/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1295048031
Products in Payments
- FARXIGA (Drug) $392.28
- JARDIANCE (Drug) $375.34
- EMGALITY (Drug) $340.80
- TRULICITY (Drug) $307.01
- UBRELVY (Drug) $299.24
- QULIPTA (Drug) $286.76
- VRAYLAR (Drug) $241.81
- BREZTRI (Drug) $222.10
- Ozempic (Drug) $192.74
- XARELTO (Drug) $164.64
- NEXPLANON (Drug) $148.43
- Rybelsus (Drug) $110.32
- XIFAXAN (Drug) $109.98
- AJOVY (Biological) $109.92
- Dayvigo (Drug) $102.86
- AUSTEDO (Drug) $96.09
- ELIQUIS (Drug) $95.50
- REXULTI (Drug) $94.21
- NURTEC ODT (Drug) $93.80
- MOUNJARO (Drug) $93.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Warrenton
Dr. James Grimes, M.d, M.D
Family Medicine — Payments: $9,747
Dr. Michael Lin, M.d, M.D
Family Medicine — Payments: $8,881
David Evans, Md, MD
Family Medicine — Payments: $6,942
Ahmad Babar, M.d, M.D
Family Medicine — Payments: $3,580
Steven Von Elten, Md, MD
Family Medicine — Payments: $3,409
Gregory Golub, Md, MD
Family Medicine — Payments: $2,548